USPTO 2015–2025 USPTO PatentsView US Corporation

Ethicon Endo-Surgery, Inc.

USPTO PatentsView assignee record — 601 granted patents across 64 technology areas, active 2015–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

601
Total patents granted
64
CPC technology areas
16.1
Avg claims per patent
-97%
5-year filing velocity

Portfolio overview

Ethicon Endo-Surgery, Inc. has been granted 601 US utility patents between 2015 and 2023, placing Ethicon Endo-Surgery, Inc. at rank #763 across all assignees tracked by PlainPatent. This portfolio spans 64 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.1 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Ethicon Endo-Surgery, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 58.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 17 grants, compared with 584 in the 2015–2019 window — a -97% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Ethicon Endo-Surgery, Inc.'s 16.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 64 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Ethicon Endo-Surgery, Inc. against peers pursuing similar technology classes.

How does Ethicon compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Ethicon holds 601 patents — placing it at rank #763 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2023

-50050100150200250 201520162017201820192020202120222023 1
USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Ethicon Endo-Surgery, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 206 34.3%
2016 200 33.3%
2017 119 19.8%
2018 43 7.2%
2019 16 2.7%
2020 7 1.2%
2021 5 0.8%
2022 4 0.7%
2023 1 0.2%

Which technologies does Ethicon Endo-Surgery, Inc. patent most?

Top 15 of 64 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#763

Across all tracked assignees

Innovation Score

58.0 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Ethicon Endo-Surgery, Inc. hold?
Ethicon Endo-Surgery, Inc. holds 601 US granted patents filed between 2015 and 2023, spanning 64 technology areas.
What is Ethicon Endo-Surgery, Inc.'s Innovation Score?
Ethicon Endo-Surgery, Inc. has an Innovation Score of 58.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Ethicon Endo-Surgery, Inc. focus on?
Ethicon Endo-Surgery, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 538 patents. The company has filed patents in 64 CPC subclasses total.
Is Ethicon Endo-Surgery, Inc.'s patent filing rate increasing or decreasing?
Ethicon Endo-Surgery, Inc.'s recent filing velocity is -97% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Ethicon Endo-Surgery, Inc.'s patents?
Ethicon Endo-Surgery, Inc.'s patents average 16.1 claims each. This falls within the standard range, providing solid legal coverage.
How is the Ethicon Endo-Surgery, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope